CCR7 and neoplasm: NSCLC cells express the C-C chemokine receptor type 7 (CCR7), and CCR7 expression-positive tumor cells are preferred to their ligand-enriched lymphatic organs, providing a basis for the priority transfer of tumor cells to specific sites [28].